Clutch Control: Changing the Speed and Direction of CAR-T Cell Therapy

por Nobili, Alberto, Kobayashi, Aya, Gedeon, Patrick C., Novina, Carl D.
Publicado 2022

Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibody

por Choi, Bryan D, Gedeon, Patrick C, Sanchez-Perez, Luis, Bigner, Darell D, Sampson, John H
Publicado 2013

First in human dose calculation of a single-chain bispecific antibody targeting glioma using the MABEL approach

por Schaller, Teilo H, Snyder, David J, Spasojevic, Ivan, Gedeon, Patrick C, Sanchez-Perez, Luis, Sampson, John H
Publicado 2020

GLP toxicology study of a fully-human T cell redirecting CD3:EGFRvIII binding immunotherapeutic bispecific antibody

por Gedeon, Patrick C., Streicker, Michael A., Schaller, Teilo H., Archer, Gary E., Jokinen, Micheal P., Sampson, John H.
Publicado 2020

Anatomy of the lung revisited by 3D-CT imaging

por Nakazawa, Seshiru, Nagashima, Toshiteru, Kawatani, Natsuko, Gedeon, Patrick C., DeSimone, Ariadne K., Igai, Hitoshi, Kosaka, Takayuki, Shirabe, Ken
Publicado 2023

The Role of Antibody-Based Therapies in Neuro-Oncology

por Ramapriyan, Rishab, Sun, Jing, Curry, Annabel, Richardson, Leland G., Ramesh, Tarun, Gaffey, Matthew A., Gedeon, Patrick C., Gerstner, Elizabeth R., Curry, William T., Choi, Bryan D.
Publicado 2023

Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma

por Suryadevara, Carter M., Desai, Rupen, Abel, Melissa L., Riccione, Katherine A., Batich, Kristen A., Shen, Steven H., Chongsathidkiet, Pakawat, Gedeon, Patrick C., Elsamadicy, Aladine A., Snyder, David J., Herndon, James E., Healy, Patrick, Archer, Gary E., Choi, Bryan D., Fecci, Peter E., Sampson, John H., Sanchez-Perez, Luis
Publicado 2018